What is the price-to-earnings ratio of Liquidia?
The price-earnings ratio of Liquidia is currently 58.84.
Liquidia P/S 2024
Liquidia P/S
58.84
Ticker
LQDA
ISIN
US53635D2027
WKN
A2JRNS
As of Nov 5, 2024, Liquidia's P/S ratio stood at 58.84, a 83.47% change from the 32.07 P/S ratio recorded in the previous year.
The Liquidia P/S history
Liquidia Aktienanalyse
What does Liquidia do?
Liquidia Corp is a biopharmaceutical company specializing in the development of novel therapeutic products using an advanced technology called Liqutex. This technology allows for precise control over the size, shape, and surface properties of particles, enabling targeted release of active ingredients in the body. The company was founded in 2004 as a spin-off from the University of North Carolina at Chapel Hill. It has been supported by prominent investors such as PPD, Inc. and New Enterprise Associates to advance the development of new drugs. Liquidia's business model is based on creating a comprehensive product portfolio with applications in various therapeutic areas, including immunology, oncology, infectious diseases, and pulmonary hypertension. The idea is to cover a wide range of applications with the Liqutex technology to increase competitiveness in the market. To achieve this, Liquidia has formed partnerships with other companies and research institutions to advance therapeutic development. For example, it collaborates with GlaxoSmithKline on the development of vaccines for pertussis and influenza. Another important aspect of Liquidia's business model is the creation of differentiated products that address a broader range of patient needs. For instance, the company has developed a novel drug combination for the treatment of pulmonary hypertension, which exhibits better efficacy and tolerability due to its specific formulation. In addition to its focus on therapeutic applications, Liquidia has also developed a range of products for industrial use. For example, it has a specialized technology for producing high-quality nanoparticles for the electronics industry. Overall, Liquidia stands out for its versatility and innovative solutions. The company has a unique technology platform that allows it to create differentiated products for both the medical and industrial sectors. Supported by an experienced management team and prominent investors, Liquidia is pursuing a holistic growth strategy to maintain a leading role in the biotechnology industry. Liquidia Corp is a biopharmaceutical company specializing in the development of novel therapeutic products using an advanced technology called Liqutex. The company was founded in 2004 as a spin-off from the University of North Carolina at Chapel Hill and has received support from investors such as PPD, Inc. and New Enterprise Associates. Liquidia's business model focuses on creating a comprehensive product portfolio with applications in various therapeutic areas, including immunology, oncology, infectious diseases, and pulmonary hypertension. The company aims to cover a wide range of applications with its Liqutex technology to increase competitiveness in the market. To achieve this, Liquidia has formed partnerships with other companies and research institutions, such as GlaxoSmithKline, to advance therapeutic development. Additionally, Liquidia prioritizes the creation of differentiated products that address a broader range of patient needs, such as a novel drug combination for the treatment of pulmonary hypertension. In addition to therapeutic applications, Liquidia has also developed products for industrial use, such as specialized technology for producing nanoparticles for the electronics industry. Liquidia distinguishes itself through its versatility and innovative solutions, with a unique technology platform and a holistic growth strategy supported by an experienced management team and prominent investors. Liquidia ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Liquidia's P/S Ratio
Liquidia's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Liquidia's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Liquidia's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Liquidia’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Liquidia stock
How has the price-earnings ratio of Liquidia changed compared to last year?
The price-to-earnings ratio of Liquidia has increased by 83.47% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Liquidia high compared to other companies?
Yes, the price-to-earnings ratio of Liquidia is high compared to other companies.
How does an increase in the price-earnings ratio of Liquidia affect the company?
An increase in the price-earnings ratio of Liquidia would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Liquidia affect the company?
A decrease in the price-earnings ratio of Liquidia would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Liquidia?
Some factors that influence the price-earnings ratio of Liquidia are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Liquidia pay?
Over the past 12 months, Liquidia paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Liquidia is expected to pay a dividend of 0 USD.
What is the dividend yield of Liquidia?
The current dividend yield of Liquidia is .
When does Liquidia pay dividends?
Liquidia pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Liquidia?
Liquidia paid dividends every year for the past 0 years.
What is the dividend of Liquidia?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Liquidia located?
Liquidia is assigned to the 'Health' sector.
Wann musste ich die Aktien von Liquidia kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Liquidia from 11/5/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/5/2024.
When did Liquidia pay the last dividend?
The last dividend was paid out on 11/5/2024.
What was the dividend of Liquidia in the year 2023?
In the year 2023, Liquidia distributed 0 USD as dividends.
In which currency does Liquidia pay out the dividend?
The dividends of Liquidia are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Liquidia
Our stock analysis for Liquidia Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Liquidia Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
